Skip to content

Validation of cholesterol absorption as measured by the dual isotope method

Validation of cholesterol absorption as measured by the dual isotope method - DAHLIA-2B

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON34258
Enrollment
7
Registered
2010-10-04
Start date
2010-09-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mild hypercholesterolemia slightly elevated cholesterol

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Healthy male and female subjects, aged 18-65 years, with an LDL-cholesterol concentration between 3.0 and 5.0 mmol/l, who participated in the Dahlia-2a study and who do not use any cholesterol-lowering medication.

Exclusion criteria

Exclusion criteria: Excluded are persons with a genetic hyperlipoproteinemia like familial hypercholesterolemia, LPL-deficiency, familial dysbeta lipoproteinemia and familial hypertriglyceridemia. Also people with diabetes mellitus, severe hypertriglyceridemia, uncontrolled hypertension or history of arterial disease including unstable angina, myocardial infarction, recent transient ischaemic attacks or a cerebro-vascular accidents, will be excluded.

Design outcomes

Primary

MeasureTime frame
The difference in plasma D7-cholesterol enrichment at T=72h, after three different ways of oral D7-cholesterol administration.

Secondary

MeasureTime frame
n.a.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)